Home
Issues
2022
June 2022 Vol 12, No 3
April 2022 Vol 12, No 2
February 2022 Vol 12, No 1
March 2022 Vol 12 Special Feature
2021
December 2021 Vol 11, No 6
October 2021 Vol 11, No 5
August 2021 Vol 11, No 4
June 2021 Vol 11, No 3
April 2021 Vol 11, No 2
March 2021 Vol 11 Special Feature
February 2021 Vol 11, No 1
2020
December 2020, Vol 10, No 6
October 2020, Vol 10, No 5
August 2020, Vol 10, No 4
June 2020, Vol 10, No 3
April 2020 Vol 10, No 2
February 2020 Vol 10, No 1
Issue Archive
Online First
Special Issues
Supplements
Guide to New FDA Approvals
2021 Year in Review
Multiple Myeloma
Advances in Dual Immunotherapy Cancer Treatments
Renal-Cell Carcinoma
Breast Cancer
Ovarian Cancer
Biosimilars
Non–Small-Cell Lung Cancer
Gastrointestinal Cancer
Categories
Conference Correspondent
ASCO 2022 - Wrap Up
Dual IO 2021 Year in Review
AACR & ASCO 2021 - Midyear Review
ASCO 2021 Breast Cancer Highlights
Web Exclusives
All Web Exclusives
Interview with the Innovators
FDA Approvals
Videos
Press Releases
Lung Cancer Monthly Minutes
Gastrointestinal Cancer Monthly Minutes
Melanoma Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Peer Review Application
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Advertise
Subscribe
Sign Up Now!
To sign up for our newsletter or print publications, please enter your contact information below.
First Name
*
Last Name
*
Email Address
*
Email Address (Verify)
*
JHOP Print Edition
We will request your mailing address on the next page.
JHOP E-Newsletters & Communications
TOP Print Edition
We will request your mailing address on the next page.
TOP E-Newsletters & Communications
I have reviewed and consent to the terms of
JHOP
's
Privacy Policy
, and
JHOP
has my permission to retain my information in its database, and to forward pertinent communications to me.
Home
Issues
2022
June 2022 Vol 12, No 3
April 2022 Vol 12, No 2
February 2022 Vol 12, No 1
March 2022 Vol 12 Special Feature
2021
December 2021 Vol 11, No 6
October 2021 Vol 11, No 5
August 2021 Vol 11, No 4
June 2021 Vol 11, No 3
April 2021 Vol 11, No 2
March 2021 Vol 11 Special Feature
February 2021 Vol 11, No 1
2020
December 2020, Vol 10, No 6
October 2020, Vol 10, No 5
August 2020, Vol 10, No 4
June 2020, Vol 10, No 3
April 2020 Vol 10, No 2
February 2020 Vol 10, No 1
Issue Archive
Online First
Special Issues
Supplements
Guide to New FDA Approvals
2021 Year in Review
Multiple Myeloma
Advances in Dual Immunotherapy Cancer Treatments
Renal-Cell Carcinoma
Breast Cancer
Ovarian Cancer
Biosimilars
Non–Small-Cell Lung Cancer
Gastrointestinal Cancer
Categories
Conference Correspondent
ASCO 2022 - Wrap Up
Dual IO 2021 Year in Review
AACR & ASCO 2021 - Midyear Review
ASCO 2021 Breast Cancer Highlights
Web Exclusives
All Web Exclusives
Interview with the Innovators
FDA Approvals
Videos
Press Releases
Lung Cancer Monthly Minutes
Gastrointestinal Cancer Monthly Minutes
Melanoma Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Peer Review Application
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Advertise
JHOP - June 2021 Vol 11, No 3
Case Reports
Original Article
FDA Oncology Update
From the Literature
Symptom Management Overview
HOPA Highlights
Case Reports
Pegaspargase-Induced Diabetic Ketoacidosis in a Patient with Acute Lymphoblastic Leukemia
Ellen Madarang, PharmD, BCOP; Leslie Gallardo, PharmD, BCPS; Terrence Bradley, MD
Read More
Original Article
Denosumab for First-Line Treatment of Hypercalcemia Associated with Malignancy: Retrospective Analysis
Katherine P. Morgan, PharmD, BCOP, CPP; Yujiao Sun, PharmD; Allison Deal; Jared Weiss, MD; Amber Cipriani, PharmD, BCOP
Read More
Immune-Related Adverse Events Linked to Immune Checkpoint Inhibitors: Retrospective Analysis of a Single-Center Veteran Population
Jessica M. Tran, PharmD, BCPS; Ni-Chi Wu, PharmD, BCOP, BCPS; Rajkumar J. Sevak, PhD, RPh; Pankaj Gupta, MD, FACP
Read More
Pharmacy Resident–Led Medication Reconciliation and Patient Education Service in Adults with Leukemia Receiving Anticancer Oral Agents: A Pilot Study
Lily Y. Jia, PharmD, BCOP; Jessie Signorelli, PharmD, BCOP; Samantha O. Luk, PharmD, BCOP; E. Bridget Kim, PharmD, BCPS, BCOP; Gayle C. Blouin, PharmD, BCOP
Read More
FDA Oncology Update
Lumakras First FDA-Approved Therapy for Advanced or Metastatic NSCLC with KRAS G12C Mutation
Read More
Rybrevant First FDA-Approved Therapy for NSCLC with EGFR Exon 20 Insertion Mutations
Read More
Zynlonta First FDA-Approved CD19-Directed Therapy for Large B-Cell Lymphoma
Read More
Jemperli First FDA-Approved Immunotherapy for Advanced Endometrial Cancer with dMMR Biomarker
Read More
Keytruda Received FDA Approval for First-Line Treatment of HER2-Positive Advanced Gastric Cancer
Read More
Opdivo First FDA-Approved Immunotherapy for First-Line Treatment of Advanced Gastric Cancer
Read More
Trodelvy Receives New Indication for Advanced Urothelial Cancer
Read More
Sarclisa Receives New Indication for Relapsed or Refractory Multiple Myeloma
Read More
From the Literature
Daily Aspirin Does Not Lower Colorectal Cancer Risk When Started After Age 70
Read More
Adjuvant Nivolumab Therapy Prolongs Disease-Free Survival in Patients with Esophageal Cancer
Read More
New Data Reveal Mismatched Need and Supply of Oncology Physicians and Pharmacists in America
Read More
Symptom Management Overview
How I Treat Anemia Associated with Lower-Risk Myelodysplastic Syndromes
Brenna Rowen, PharmD, BCOP
Read More
HOPA Highlights
The Impact of Racial Disparities in Cancer Care: Racism a Risk Factor for Poor Clinical Outcomes
Read More
Eliminating Structural Racism in Oncology Pharmacy: Individual and Organizational Responsibility
Read More
New Opportunities for Pharmacists in Clinical Trials and Drug Development After COVID-19
Read More
Immunotherapy Continues to Transform the Treatment Landscape for Advanced Non–Small-Cell Lung Cancer
Read More
Cancer Pain Management and the Opioid Conundrum: Optimizing Outcomes, Minimizing Risks
Read More
Managing Thromboembolism in Patients with Cancer: Which Are the Preferred Anticoagulants?
Read More
Privacy policy
Terms of Use
Home
About
Subscribe
Advertise
Contact Us
Copyright © Green Hill Healthcare Communications, LLC. All rights reserved.